$9.03
-0.01000-0.11%
At close: -
$8.99
-0.04-0.44%
After Hours: Dec 20, 4:06 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Aurinia Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.